Neurocrine Biosciences reported $1.54B in Equity Capital and Reserves for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 425.69M 9.16M
Acorda Therapeutics ACOR:US USD 75.77M 12.14M
Agios Pharmaceuticals AGIO:US USD 1.05B 73.9M
ALKERMES ALKS:US USD 1.04B 39.47M
Alnylam Pharmaceuticals ALNY:US USD -67638000 243.68M
Amgen AMGN:US USD 3.65B 1.23B
Aptinyx Inc APTX:US USD 48.79M 13.31M
Biogen BIIB:US USD 12.78B 903M
Biomarin Pharmaceutical BMRN:US USD 4.57B 63.71M
Cytokinetics CYTK:US USD -15977000 127.39M
Enanta Pharmaceuticals ENTA:US USD 321.33M 16.69M
Exelixis EXEL:US USD 2.49B 100.14M
Gilead Sciences GILD:US USD 21.06B 821M
Halozyme Therapeutics HALO:US USD 96.99M 196.18M
Intercept Pharmaceuticals ICPT:US USD 107.68M 477.51M
Intra Cellular Therapies ITCI:US USD 685.42M 36.78M
IONIS PHARMACEUT IONS:US USD 594.36M 30.36M
Nektar Therapeutics NKTR:US USD 412.22M 46.51M
Neurocrine Biosciences NBIX:US USD 1.54B 121.2M
Prothena PRTA:US USD 404.65M 2.65M
Regeneron Pharmaceuticals REGN:US USD 21.44B 751M
Repligen RGEN:US USD 1.84B 29.74M
Rigel Pharmaceuticals RIGL:US USD 19.83M 23.51M
Sarepta Therapeutics SRPT:US USD 430.84M 295.62M
Teva Pharmaceutical TEVA:IT USD 8.77B 269M
Ultragenyx Pharmaceutical RARE:US USD 468.83M 209.24M
Vertex Pharmaceuticals VRTX:US USD 13.03B 1.1B
Xoma XOMA:US USD 130.32M 4.63M
YTE INCY:US USD 4.23B 141.59M